Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Xinyi Jiang"'
Autor:
Wei-Hsuan Lo-Ciganic, Xinyi Jiang, Vakaramoko Diaby, Haesuk Park, Robert Parker, Scott Martin Vouri
Publikováno v:
J Manag Care Spec Pharm
BACKGROUND: Patients with substance use disorders (SUD) and chronic hepatitis C virus infection (HCV) have limited access to direct-acting antivirals (DAAs) due to multilevel issues related to providers (eg, concern about reinfection); patients (eg,
Autor:
David R. Nelson, Wei-Hsuan Lo-Ciganic, Robert L. Cook, Xinyi Jiang, Vincent Lo Re, Lindsey M. Childs-Kean, Hyun Jin Song, Haesuk Park
Publikováno v:
Hepatobiliary Surg Nutr
BACKGROUND AND AIMS Our aim was to evaluate the impact of direct-acting antivirals (DAAs) on decompensated cirrhosis (DCC) and HCC in patients with chronic HCV and substance use disorder (SUD) compared with those without an SUD. APPROACH AND RESULTS
Publikováno v:
International Journal of Biological Sciences
Hepatitis B surface antigen (HBsAg) and Hepatitis B surface antibody (anti-HBs) were reported simultaneously among Hepatitis B virus (HBV) infections. HBsAg is a specific indicator of acute or chronic HBV infections, while anti-HBs is a protective an
Autor:
Yi Liu, Xiaohong Dong, Wei Ren, Dongxu Liu, Qianqian Yan, Jiahao Zhang, Xinyi Jiang, Xinyi Xu, Chunpeng Liu, Rui Zhang, Shijie Zhang, Zhaoli Geng
Publikováno v:
Inflammation. 44:1302-1314
Periodontitis is a widespread human chronic inflammatory disease of the tooth-surrounding tissues, which induces the destruction of periodontium and pathologic loss of teeth among adults. It has been reported that interleukin (IL)-17 was significantl
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 5, Iss 2, Pp 203-216 (2021)
Hepatology Communications, Vol 5, Iss 2, Pp 203-216 (2021)
Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA requirements on treatment uptake and to determine the factors
Autor:
Gerald A. Grant, Sergio Fitch, Christine Wang, Viola Caretti, Sauradeep Sinha, Fan Yang, Xinyi Jiang, Michelle Monje, Christy Wilson, Anitha Ponnuswami
Publikováno v:
Acta Biomater
Brain tumors exhibit vast genotypic and phenotypic diversity depending on patient age and anatomical location. Hydrogels hold great promise as 3D in vitro models for studying brain tumor biology and drug screening, yet previous studies were limited t
Autor:
Shengchang Zhang, Mohnad Abdalla, Zhenmei Yang, Tang Chunwei, Xinyi Jiang, Wei Du, Anning Li, Jiawen Xu, Ying Liu, Chen Chen, Chongdeng Shi, Jing Zhang, Peng Sun, Rui Zhang
Publikováno v:
Theranostics
Rationale: Vascular abnormality stemming from the hypoxia-driven elevation of proangiogenic factors is a hallmark for many solid malignant tumors, including colorectal cancer (CRC) and its liver metastasis. We report a hypoxia-triggered liposome-supp
Autor:
Xinyi Jiang, Gong Feng, Baobing Zhao, Bei Liu, Jian Liu, Degang Kong, Tao Jiang, Cheng Lou, Steven L. Carroll
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 27, Iss 1, Pp 1729-1740 (2020)
article-version (VoR) Version of Record
Drug Delivery, Vol 27, Iss 1, Pp 1729-1740 (2020)
Chemoembolization for hepatocellular carcinoma (HCC) is often suboptimal due to multiple involved signaling and lack of effective drugs. Arsenic trioxide (ATO) is a potent chemotherapeutic agent, which can target multiple signaling and have substanti
Publikováno v:
Drug Alcohol Depend
Background Deaths involving illicitly manufactured fentanyl (IMF) have increased since 2013 in the United States. Little research has examined individuals using IMF. This study aims to explore the characteristics of US adults who used IMF, heroin, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc36966cffa5b29e39bf3cdff183ce90
https://europepmc.org/articles/PMC8671312/
https://europepmc.org/articles/PMC8671312/
Autor:
Rachel Reise, Scott Martin Vouri, Todd M. Manini, Earl J. Morris, Xinyi Jiang, Silken A Usmani, Almut G. Winterstein, Carl J. Pepine, Daniel C. Malone
Publikováno v:
Pharmacoepidemiol Drug Saf
OBJECTIVES: To evaluate the prescription sequence symmetry analysis assumption regarding balance between marker drug (i.e., medication used to treat a drug-induced adverse event) initiation rates before and after initiation of an index drug (i.e., me